Data showed that melittin can treat RA through a multi-target and multi-pathway mechanism, and melittin’s therapeutic effect was believed to involve important hub targets such as STAT3, AKT1, TNF, JUN, IL1B, MAPK, and VEGFA. This evidence concerns the gene VEGFA and rheumatoid arthritis.